Boston keratoprosthesis type 1
Showing 51 - 75 of >10,000
Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2) Trial in Worldwide (TAK-994, Placebo)
Terminated
- Narcolepsy Type 1 (NT1)
- Narcolepsy Type 2 (NT2)
- TAK-994
- Placebo
-
Alabaster, Alabama
- +77 more
Oct 5, 2022
Type 1 Diabetes Trial in France, United States (Omnipod 5 System)
Recruiting
- Type 1 Diabetes
- Omnipod 5 System
-
Palo Alto, California
- +13 more
Sep 8, 2022
Gastroparesis Registry 4
Not yet recruiting
- Gastroparesis
- +5 more
-
Scottsdale, Arizona
- +5 more
May 10, 2023
Alcohol-Related Disorders, Substance-Related Disorders, Mental Health Trial in United States (Screening, Brief Intervention, and
Enrolling by invitation
- Alcohol-Related Disorders
- +9 more
- Screening, Brief Intervention, and Referral to Treatment (SBIRT)
-
Boston, Massachusetts
- +3 more
Jun 21, 2023
Atopic Dermatitis, Type 1 Hypersensitivity Trial in Australia, Puerto Rico, United States (STMC-103H, Placebo)
Recruiting
- Atopic Dermatitis
- Type 1 Hypersensitivity
- STMC-103H
- Placebo
-
Tucson, Arizona
- +25 more
Dec 1, 2022
Diabetes, Type 1 Trial in Boston (high GI meal, low GI meal, euglycemic insulin clamp)
Completed
- Diabetes Mellitus, Type 1
- high GI meal
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
May 25, 2021
Spinal Muscular Atrophy Type I, Spinal Muscular Atrophy Type II, Spinal Muscular Atrophy Type III Trial in Worldwide
Active, not recruiting
- Spinal Muscular Atrophy Type I
- +3 more
- Onasemnogene Abeparvovec-xioi
-
Palo Alto, California
- +30 more
Dec 1, 2022
Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)
Enrolling by invitation
- Primary Hyperoxaluria Type 1 (PH1)
- +5 more
-
San Francisco, California
- +19 more
Jun 22, 2022
Type 1 Diabetes, Hypoglycemia Trial in United Kingdom, United States (HARPdoc courses, BGAT courses)
Completed
- Type 1 Diabetes Mellitus
- Hypoglycemia
- HARPdoc courses
- BGAT courses
-
Boston, Massachusetts
- +3 more
Sep 1, 2021
TrialNet Pathway to Prevention of T1D
Recruiting
- Diabetes Mellitus, Type 1
-
Orange, California
- +21 more
Feb 18, 2022
Type 1 Diabetes, New-onset Type 1 Diabetes, T1DM Trial in Australia, United States (Tocilizumab (TCZ), Placebo, Standard of
Completed
- Type 1 Diabetes Mellitus
- +3 more
- Tocilizumab (TCZ)
- +2 more
-
San Francisco, California
- +18 more
Aug 16, 2021
NF1, Low-grade Glioma Trial in United States (Poly ICLC)
Recruiting
- NF1
- Low-grade Glioma
- Poly ICLC
-
Birmingham, Alabama
- +18 more
Jan 5, 2023
Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)
Recruiting
- Metastatic Malignant Solid Neoplasm
- Unresectable Malignant Solid Neoplasm
- Biopsy
- +2 more
-
Boston, Massachusetts
- +2 more
Jan 25, 2023
Type 1 Diabetes Trial in United States (t:slim X2 with Control-IQ Technology & Dexcom G6 CGM, t:slim X2 with Basal-IQ & Dexcom
Completed
- Type 1 Diabetes Mellitus
- t:slim X2 with Control-IQ Technology & Dexcom G6 CGM
- t:slim X2 with Basal-IQ & Dexcom G6 CGM
-
Santa Barbara, California
- +6 more
Jul 31, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States
Recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Biopsy
- +7 more
-
Aurora, Colorado
- +7 more
Nov 29, 2022
NF1, Congenital Pseudarthrosis of Tibia Trial in Australia, United States (INFUSE Bone Graft (BMP-2), Control Group)
Terminated
- NF1
- Congenital Pseudarthrosis of Tibia
- INFUSE Bone Graft (BMP-2)
- Control Group
-
Birmingham, Alabama
- +15 more
Sep 29, 2021
Human Immunodeficiency Virus Trial in Boston (Ad26.Mos4.HIV, MVA-Mosaic, Clade C gp140 + Mosaic gp140)
Completed
- Human Immunodeficiency Virus
- Ad26.Mos4.HIV
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 7, 2022
Diabetes, Type 1 Diabetes, Diabetes, Type 1 Trial in United States (Bionic Pancreas)
Completed
- Diabetes Mellitus
- +2 more
- Bionic Pancreas
-
Orange, California
- +15 more
Jan 17, 2022
Type 1 Diabetes, Monogenic Diabetes Trial in Boston (Metformin Extended Release Oral Tablet, Sitagliptin)
Enrolling by invitation
- Type 1 Diabetes
- Monogenic Diabetes
- Metformin Extended Release Oral Tablet
- Sitagliptin
-
Boston, MassachusettsJoslin Diabetes Center
Jan 4, 2022
Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
- +16 more
- P-PSMA-101 CAR-T cells
- Rimiducid
-
Duarte, California
- +9 more
Nov 15, 2022
Actinic Keratosis Trial in United States (Biopsy, Calcipotriene, Fluorouracil)
Not yet recruiting
- Actinic Keratosis
- Biopsy
- +2 more
-
Tucson, Arizona
- +3 more
Jan 25, 2023